دورية أكاديمية

Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet Nam.

التفاصيل البيبلوغرافية
العنوان: Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet Nam.
المؤلفون: Tran PMT; Friends for International TB Relief, Ha Noi, Viet Nam., Dam TA; Friends for International TB Relief, Ha Noi, Viet Nam., Huynh HB; Friends for International TB Relief, Ha Noi, Viet Nam., Codlin AJ; Friends for International TB Relief, Ha Noi, Viet Nam., Forse RJ; Friends for International TB Relief, Ha Noi, Viet Nam., Dang HMT; Pham Ngoc Thach Hospital, Ho Chi Minh City, Viet Nam., Truong VV; Pham Ngoc Thach Hospital, Ho Chi Minh City, Viet Nam., Nguyen LH; Pham Ngoc Thach Hospital, Ho Chi Minh City, Viet Nam., Nguyen HB; National Lung Hospital, Ha Noi, Viet Nam., Nguyen NV; National Lung Hospital, Ha Noi, Viet Nam., Creswell J; Stop TB Partnership, Geneva, Switzerland., Meralli F; mClinica, Singapore, Singapore., Morishita F; World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Dong TTT; Friends for International TB Relief, Ha Noi, Viet Nam., Nguyen GH; IRD VN, Ho Chi Minh City, Viet Nam., Vo LNQ; Friends for International TB Relief, Ha Noi, Viet Nam.; IRD VN, Ho Chi Minh City, Viet Nam.
المصدر: PLOS global public health [PLOS Glob Public Health] 2022 Oct 17; Vol. 2 (10), pp. e0000257. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, California : Public Library of Science, [2021]-
مستخلص: Pharmacies represent a key health system entry point for people with TB in Viet Nam, but high fragmentation hinders their broader engagement. Professional networking apps may be able to facilitate pharmacy engagement for systematic TB screening and referral. Between September and December 2019, we piloted the use of a social networking app, SwipeRx, to recruit pharmacists for a TB referral scheme across four districts of Ho Chi Minh City, Viet Nam. We measured chest X-ray (CXR) referrals and TB detection yields at participating pharmacies and fielded 100 acceptability surveys, divided into pharmacists who did and did not make a CXR referral. We then fitted mixed-effect odds proportional models to explore acceptability factors that were associated with making a CXR referral. 1,816 push notifications were sent to pharmacists via the SwipeRx app and 78 indicated their interest in participating; however, only one was within the pilot's intervention area. Additional in-person outreach resulted in the recruitment of 146 pharmacists, with 54 (37.0%) making at least one CXR referral. A total of 182 pharmacy customers were referred, resulting in a total of 64 (35.2%) CXR screens and seven people being diagnosed with TB. Compared to pharmacists who did not make any CXR referrals, pharmacists making at least one CXR referral understood the pilot's objectives more clearly (aOR = 2.6, 95% CI: 1.2-5.8) and they believed that TB screening increased customer trust (aOR = 2.7, 95% CI: 1.2-5.8), benefited their business (aOR = 2.8, 95% CI: 1.3-6.2) and constituted a competitive advantage (aOR = 4.4, 95% CI: 1.9-9.9). They were also more confident in using mHealth apps (aOR = 3.1, 95 CI%: 1.4-6.8). Pharmacies can play an important role in early and increased TB case finding. It is critical to highlight the value proposition of TB referral schemes to their business during recruitment. Digital networking platforms, such as SwipeRx, can facilitate referrals for TB screening by pharmacists, but their ability to identify and recruit pharmacists requires optimization, particularly when targeting specific segments of a nation-wide digital network.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2022 TRAN et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
References: Int J Tuberc Lung Dis. 2003 Dec;7(12):1147-53. (PMID: 14677889)
Int J Tuberc Lung Dis. 2012 Dec;16(12):1625-9. (PMID: 23131260)
Trop Med Infect Dis. 2020 Sep 14;5(3):. (PMID: 32937757)
BMC Health Serv Res. 2017 Jan 26;17(1):88. (PMID: 28126032)
Public Health Rep. 2006 May-Jun;121(3):228-34. (PMID: 16640143)
Trop Med Infect Dis. 2020 Feb 14;5(1):. (PMID: 32075073)
J Infect Dis. 2017 Nov 6;216(suppl_7):S686-S695. (PMID: 29117351)
West J Med. 1985 Mar;142(3):409-12. (PMID: 3993022)
Indian J Med Sci. 2008 Mar;62(3):118-23. (PMID: 18376086)
Int J Tuberc Lung Dis. 2012 Aug;16(8):1086-91. (PMID: 22687275)
Health Policy Plan. 2001 Mar;16(1):68-73. (PMID: 11238433)
BMJ Glob Health. 2019 May 13;4(3):e001417. (PMID: 31179037)
Indian J Tuberc. 2020 Apr;67(2):189-201. (PMID: 32553311)
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):983-990. (PMID: 30092862)
Implement Sci. 2021 May 19;16(1):54. (PMID: 34011353)
Am J Trop Med Hyg. 2020 Jul;103(1):221-230. (PMID: 32372744)
Am J Pharm Educ. 2016 Mar 25;80(2):18. (PMID: 27073271)
Online J Public Health Inform. 2018 Sep 21;10(2):e215. (PMID: 30349633)
Health Informatics J. 2016 Jun;22(2):99-112. (PMID: 25038200)
PLoS One. 2020 Nov 23;15(11):e0241437. (PMID: 33226990)
BMC Infect Dis. 2020 Aug 5;20(1):579. (PMID: 32758160)
Int J Tuberc Lung Dis. 2000 Nov;4(11):1052-9. (PMID: 11092718)
PLoS One. 2021 May 7;16(5):e0250644. (PMID: 33961645)
Trop Med Infect Dis. 2020 Nov 30;5(4):. (PMID: 33265972)
J Clin Epidemiol. 2002 Nov;55(11):1148-55. (PMID: 12507680)
Trop Med Int Health. 2011 Oct;16(10):1260-7. (PMID: 21692960)
Health Policy Plan. 2001 Mar;16(1):47-54. (PMID: 11238430)
Am J Health Syst Pharm. 2008 Mar 1;65(5):462-7. (PMID: 18281740)
Infect Dis Poverty. 2020 Dec 9;9(1):166. (PMID: 33292638)
J Pharm Policy Pract. 2017 Jan 18;10:6. (PMID: 28116106)
PLoS Med. 2019 Sep 3;16(9):e1002890. (PMID: 31479454)
Int J Tuberc Lung Dis. 2002 Feb;6(2):171-3. (PMID: 11931419)
Health Policy. 1998 Aug;45(2):81-97. (PMID: 10186226)
Drug Alcohol Rev. 2008 Jul;27(4):420-8. (PMID: 18584393)
Int J Health Policy Manag. 2017 Jan 22;6(6):305-308. (PMID: 28812822)
J Clin Tuberc Other Mycobact Dis. 2019 Dec 02;18:100135. (PMID: 31872080)
Int J Tuberc Lung Dis. 1999 Nov;3(11):992-1000. (PMID: 10587321)
Trop Med Int Health. 2014 Sep;19(9):1076-81. (PMID: 24995611)
Lancet Reg Health West Pac. 2020 Nov 28;5:100059. (PMID: 34327397)
Int J Tuberc Lung Dis. 2007 Aug;11(8):893-7. (PMID: 17705956)
BMC Public Health. 2020 Jun 15;20(1):934. (PMID: 32539700)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
تواريخ الأحداث: Date Created: 20230324 Latest Revision: 20230505
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10021543
DOI: 10.1371/journal.pgph.0000257
PMID: 36962503
قاعدة البيانات: MEDLINE
الوصف
تدمد:2767-3375
DOI:10.1371/journal.pgph.0000257